We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On 28 January 2010, the FSA published Consultation Paper 103: Effective corporate governance (Significant influence controlled functions and the Walker review) (CP103
The FSA has published a speech given by Sally Dewar (Managing Director, Risk, FSA) which is entitled Taking the FSA's corporate governance agenda forward
